OCEAW
Income statement / Annual
Last year (2022), Ocean Biomedical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Ocean Biomedical, Inc.'s net income was $565,470.00.
See Ocean Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$33.93 M
|
$49,000.00
|
$35,000.00
|
| General & Administrative
Expenses |
$0.00
|
$28.41 M
|
$1.60 M
|
$197,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.48 M
|
$28.41 M
|
$1.60 M
|
$197,000.00
|
| Other Expenses |
$0.00 |
$1,000.00 |
-$1,000.00 |
$0.00 |
| Operating Expenses |
$2.48 M |
$62.35 M |
$1.65 M |
$232,000.00 |
| Cost And Expenses |
$2.48 M |
$62.35 M |
$1.65 M |
$232,000.00 |
| Interest Income |
$1.52 M |
$2,448.00 |
$0.00 |
$0.00 |
| Interest Expense |
$691.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.52 M
|
$236,558.00
|
$206,297.00
|
$171,860.00
|
| EBITDA |
-$957,739.00
|
-$564,110.00
|
-$1.65 M
|
-$232,000.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.52 M
|
$61.78 M
|
-$1,000.00
|
$0.00
|
| Income Before Tax |
-$958,430.00 |
-$62.34 M |
-$1.65 M |
-$232,000.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$236,558.00 |
-$206,297.00 |
-$171,860.00 |
| Net Income |
$565,470.00 |
-$62.34 M |
-$1.65 M |
-$232,000.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-0.0263 |
-4.71 |
-0.0818 |
-0.0115 |
| EPS Diluted |
-0.0263 |
-4.71 |
-0.0818 |
-0.0115 |
| Weighted Average Shares
Out |
$36.50 M
|
$13.23 M
|
$20.20 M
|
$20.20 M
|
| Weighted Average Shares
Out Diluted |
$36.50 M
|
$13.23 M
|
$20.20 M
|
$20.20 M
|
| Link |
|
|
|
|
